Macedo Patricia, Coker Robina K, Partridge Martyn R
Department of Respiratory Medicine, Hammersmith Hospitals NHS Trust, London, UK.
BMC Pulm Med. 2007 Mar 13;7:3. doi: 10.1186/1471-2466-7-3.
Benchmarking is the comparison of a process to the work or results of others. We conducted a national benchmarking exercise to determine how UK pulmonologists manage common clinical scenarios in diffuse parenchymal lung disease (DPLD), and to determine current use and availability of investigative resources. We compared management decisions to existing international guidelines.
Consultant members of the British Thoracic Society were mailed a questionnaire seeking their views on the management of three common scenarios in DPLD. They were asked to choose from various management options for each case. Information was also obtained from the respondents on time served as a consultant, type of institution in which they worked and the availability of a local radiologist and histopathologist with an interest/expertise in thoracic medicine.
370 out of 689 consultants replied (54% response rate). There were many differences in the approach to the management of all three cases. Given a scenario of relapsing pulmonary sarcoidosis in a lady with multiple co-morbidities, half of respondents would institute treatment with a variety of immunosuppressants while a half would simply observe. 42% would refer a 57-year old lady with new onset DPLD for a surgical lung biopsy, while a similar number would not. 80% would have referred her for transplantation, but a fifth would not. 50% of consultants from district general hospitals would have opted for a surgical biopsy compared to 24% from cardiothoracic centres: this may reflect greater availability of a radiologist with special interest in thoracic imaging in cardiothoracic centres, obviating the need for tissue diagnosis. Faced with an elderly male with high resolution CT thorax (HRCT) evidence of usual interstitial pneumonia (UIP), three quarters would observe, while a quarter would start immunosuppressants. 11% would refer for a surgical biopsy. 14% of UK pulmonologists responding to the survey revealed they had no access to a radiologist with an interest in thoracic radiology.
From our survey, it appears there is a lack of consensus in the management of DPLD. This may reflect lack of evidence, lack of resources or a failure to implement current guidelines.
基准测试是将一个流程与其他人的工作或成果进行比较。我们开展了一项全国性的基准测试活动,以确定英国肺科医生如何处理弥漫性实质性肺疾病(DPLD)中的常见临床情况,并确定当前调查资源的使用情况和可获得性。我们将管理决策与现有的国际指南进行了比较。
向英国胸科学会的顾问成员邮寄了一份问卷,征求他们对DPLD中三种常见情况管理的意见。要求他们为每个病例从各种管理选项中进行选择。还从受访者那里获得了担任顾问的时长、工作所在机构的类型以及当地对胸科医学有兴趣/专长的放射科医生和组织病理学家的可获得性等信息。
689名顾问中有370名回复(回复率为54%)。在所有三个病例的管理方法上存在许多差异。对于一位患有多种合并症且复发性肺结节病的女性患者,一半的受访者会使用多种免疫抑制剂进行治疗,而另一半则会选择单纯观察。42%的受访者会将一名新发DPLD的57岁女性转诊进行外科肺活检,而同样比例的人则不会。80%的人会将她转诊进行移植,但五分之一的人不会。与心胸中心24%的顾问相比,地区综合医院50%的顾问会选择进行外科活检:这可能反映出心胸中心有更多对胸部影像有特殊兴趣的放射科医生,从而无需进行组织诊断。面对一名胸部高分辨率CT(HRCT)显示有普通型间质性肺炎(UIP)的老年男性,四分之三的人会选择观察,而四分之一的人会开始使用免疫抑制剂。11%的人会转诊进行外科活检。参与调查的英国肺科医生中有14%表示他们无法接触到对胸部放射学有兴趣的放射科医生。
从我们的调查来看,DPLD的管理似乎缺乏共识。这可能反映出缺乏证据、资源不足或未能实施当前指南。